-
RESTRICTED CONTRACT MARKETS FOR CME RULE 552 (“DUAL TRADING RESTRICTIONS”)
-
-
- To
- Members, Member Firms and Market Users
-
- From
- Market Regulation
-
- #
- SER-7147
-
- Notice Date
- 29 July 2014
-
- Effective Date
- 01 August 2014
-
The Exchange has approved the following list of restricted markets for the implementation of CME Rule 552 (“Dual Trading Restrictions”).
Please note that effective August 1, 2014, the dual trading restriction will be removed from the quarterly cycle 4-Year MidCurve options.
Dual Trading Restrictions will continue to be applicable to the following contracts:
• EURODOLLAR OPTIONS: Dual trading is restricted in the following contract month positions, up to but not including the last five business days of the contract month:
o First and second contract month position quarterly Eurodollar options.
• EURODOLLAR MIDCURVE OPTIONS: Dual trading will be restricted in the following contract month positions, up to but not including the last five business days of the contract month:
o First, second and third contract month position quarterly cycle 1-Year Eurodollar MidCurve options;
o First contract month position serial 1-Year Eurodollar MidCurve options;
o First, second and third contract month position quarterly cycle 2-Year Eurodollar MidCurve options;
o First and second contract month position serial 2-Year Eurodollar MidCurve options;
o First and second contract month position quarterly 3-Year Eurodollar MidCurve options; and
o First and second contract month position serial 3-Year Eurodollar MidCurve options.
• S&P 500® INDEX OPTIONS: Dual trading is restricted in first serial contract month position S&P 500 options, up to but not including the last five business days of the contract month.
The Exchange regularly reviews historical volume data in order to determine those contracts and contract months deemed mature and liquid pursuant to CME Rule 552. Any new restrictions on dual trading will occur only after prior notice has been provided to shareholder/members.
Please see below for information on the date ranges during which dual trading is restricted in each of the restricted contract months.
EFFECTIVE DATES OF DUAL TRADING RESTRICTIONS ON CME PRODUCTS
The following schedule details the effective periods of the dual trading restrictions by contract month for CME products.
DUAL TRADING RESTRICTED CONTRACT MONTHS
CME Product
Contract Month
Restricted Dates
Date Lifted
Termination of Trading Date
ED Options
(Quarterlies)
Sep 2014
3/11/14
To
9/8/14
9/9/14
9/15/14
Dec 2014
6/11/14
To
12/8/14
12/9/14
12/15/14
Mar 2015
9/10/14
To
3/9/15
3/10/15
3/16/15
Jun 2015
12/10/14
To
6/8/15
6/9/15
6/15/15
Sep 2015
3/11/15
To
9/4/15
9/8/15
9/14/15
1-Year ED
MidCurve Options
(Quarterlies)
Sep 2014
4/1/14
To
9/5/14
9/8/14
9/12/14
Dec 2014
4/1/14
To
12/5/14
12/8/14
12/12/14
Mar 2015
6/10/14
To
3/6/15
3/9/15
3/13/15
Jun 2015
9/9/14
To
6/5/15
6/8/15
6/12/15
1-Year ED
MidCurve Options
(Serials)
Aug 2014
7/8/14
To
8/8/14
8/11/14
8/15/14
Oct 2014
8/12/14
To
10/3/14
10/6/14
10/10/14
2-Year ED
MidCurve Options
(Quarterlies)
Sep 2014
4/1/14
To
9/5/14
9/8/14
9/12/14
Dec 2014
4/1/14
To
12/5/14
12/8/14
12/12/14
Mar 2015
6/10/14
To
3/6/15
3/9/15
3/13/15
Jun 2015
9/9/14
To
6/5/15
6/8/15
6/12/15
2-Year ED
MidCurve Options
(Serials)
Aug 2014
5/19/14
To
8/8/14
8/11/14
8/15/14
Oct 2014
7/14/14
To
10/3/14
10/6/14
10/10/14
Nov 2014
8/15/14
To
11/7/14
11/10/14
11/14/14
3-Year ED
MidCurve Options
(Quarterlies)
Sep 2014
4/1/14
To
9/5/14
9/8/14
9/12/14
Dec 2014
6/10/14
To
12/5/14
12/8/14
12/12/14
Mar 2015
9/9/14
To
3/6/15
3/9/15
3/13/15
Jun 2015
12/9/14
To
6/5/15
6/8/15
6/12/15
3-Year ED
MidCurve Options
(Serials)
Aug 2014
5/19/14
To
8/8/14
8/11/14
8/15/14
Oct 2014
7/14/14
To
10/3/14
10/6/14
10/10/14
Nov 2014
8/15/14
To
11/7/14
11/10/14
11/14/14
SP Options
(Serials)
Aug 2014
7/18/14
To
8/8/14
8/11/14
8/15/14
Oct 2014
8/12/14
To
10/10/14
10/13/14
10/17/14
Nov 2014
10/14/14
To
11/14/14
11/17/14
11/21/14
If you have any questions regarding the dual trading restrictions, please contact Shantell Stanberry, Data Investigator, Market Regulation, at 312.435.3642.
For media inquiries concerning this Special Executive Report, please contact CME Group Corporate Communications at 312.930.3434 or news@cmegroup.com.
-
© 2024 CME Group Inc. All rights reserved.